Key terms
About VBIV
VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601. It also develops an enveloped virus-like particle (eVLP) platform technology, which allows the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on April 9, 1965 and is headquartered in Cambridge, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest VBIV news
No recent news articles are available for VBIV
No recent press releases are available for VBIV
VBIV Financials
Key terms
Ad Feedback
VBIV Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
VBIV Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range